Feasibility of BIBF1120 (nintedanib) combined with low-dose cytarabine in elderly patients with AML ineligible for intensive treatment.

被引：1
|
作者：
Krug, Utz [1 ]
Knoblauch, Nicola [1 ]
Gerss, Joachim [1 ]
Schliemann, Christoph [1 ]
Wiebe, Stefanie [1 ]
Mueller-Tidow, Carsten [1 ]
Berdel, Wolfgang E. [1 ]
机构：
[1] Univ Hosp Muenster, Munster, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7053
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients wan high-risk AML
    Hong, Ming
    Zhu, Han
    Sun, Qian
    Zhu, Yu
    Miao, Yi
    Yang, Hui
    Qiu, Hai-Rong
    Li, Jian-Yong
    Qian, Si-Xuan
    AGING-US, 2020, 12 (07): : 5792 - 5811
  • [42] Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience
    Heiblig, Mael
    Elhamri, Mohamed
    Tigaud, Isabelle
    Plesa, Adriana
    Barraco, Fiorenza
    Labussiere, Helene
    Ducastelle, Sophie
    Michallet, Mauricette
    Nicolini, Franck
    Plesa, Claudiu
    Wattel, Eric
    Salles, Gilles
    Thomas, Xavier
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
  • [43] Indirect Comparative Effectiveness of Treatments for Older Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (NIC): Combinations Glasdegib plus Low-Dose Cytarabine (GLAS plus LDAC) vs Decitabine or Venetoclax plus LDAC
    Tremblay, G.
    Westley, T.
    Bell, T. J.
    Cappelleri, J. C.
    Chan, G.
    Hearnden, J.
    Forsythe, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 39 - 39
  • [44] Clofarabine Plus Low-Dose Cytarabine Induction Followed by Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with Decitabine as Frontline Therapy for Patients (pts) with Acute Myeloid Leukemia (AML) ≥ 60 Years (yrs)
    Parikh, Sameer A.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Kadia, Tapan
    Ravandi, Farhad
    Ferrajoli, Alessandra
    Estrov, Zeev
    Feliu, Jenny
    Faderl, Stefan
    BLOOD, 2009, 114 (22) : 813 - 813
  • [45] Low-dose Cytarabine plus Aclarubicin for Patients with Previously Untreated Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Ineligible for Standard-dose Cytarabine plus Anthracycline
    Fukushima, Toshihiro
    Kawabata, Hiroshi
    Sawaki, Toshioki
    Satoh, Tomomi
    Nakamura, Takuji
    Iwao, Haruka
    Nakajima, Akio
    Sakai, Tomoyuki
    Miki, Miyuki
    Fujita, Yoshimasa
    Tanaka, Masao
    Kawanami, Takafumi
    Masaki, Yasufumi
    Okazaki, Toshiro
    Umehara, Hisanori
    ANTICANCER RESEARCH, 2012, 32 (04) : 1347 - 1353
  • [46] LOW-DOSE CYTARABINE (ARA-C) IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    MUFTI, GJ
    OSCIER, DG
    HAMBLIN, TJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 571 - 571
  • [47] A Randomized Comparison of Liposomal Daunorubicin/Daunorubicin Combined with Low-Dose Cytarabine and Etoposide or High-Dose Cytarabine and Fludarabine in Induction Treatment of Pediatric AML Using MRD- Based Risk Stratification in the NOPHO-DBH AML 2012 Protocol
    De Moerloose, Barbara
    Arad-Cohen, Nira
    Cheuk, Daniel
    Fernandez Navarro, Jose Maria
    Hasle, Henrik
    Jahnukainen, Kirsi
    Kaspers, Gertjan J. L.
    Kovalova, Zhanna
    Lausen, Birgitte
    Noren-Nystrom, Ulrika
    Palle, Josefine
    Pasauliene, Ramune
    Pronk, Cornelis Jan
    Saks, Kadri
    Tierens, Anne Maria
    Zeller, Bernward
    Abrahamsson, Jonas
    BLOOD, 2023, 142
  • [48] Treatment of Elderly and Unfit AML Patients with Prolonged Administration of Low Dose Cytarabine and Thioguanine Achieves High Complete Remission Rates in an Outpatient Setting
    Arthur, Christopher K.
    Jeffrey, Anthony
    Forbes, Molly
    Yip, Eva
    Katsioulas, Vicki
    Stevenson, William S.
    BLOOD, 2018, 132
  • [49] Results of omacetaxine plus low-dose cytarabine (LD-araC) in older patients with acute myeloid leukemia (AML).
    Kadia, Tapan M.
    Daver, Naval Guastad
    Ravandi, Farhad
    Jabbour, Elias
    Pemmaraju, Naveen
    Pierce, Sherry
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy
    Wei Wu
    Yan Lin
    Lili Xiang
    Weimin Dong
    Xiaoying Hua
    Yun Ling
    Haiqian Li
    Feng Yan
    Xiaobao Xie
    Weiying Gu
    Annals of Hematology, 2016, 95 : 1051 - 1057
12345